Search results for " Major"

showing 10 items of 361 documents

Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression

2011

Background: Mood disorders are associated with the highest increase of attempted and completed suicide. Suicidality in major depressive disorder and in schizophrenia has been associated with reduced gray matter volumes in orbitofrontal cortex. Lithium reduces the suicide risk of patients with bipolar disorder (BD) to the same levels of the general population, and can increase GM volumes. We studied the effect of a positive history of attempted suicide and ongoing lithium treatment on regional GM volumes of patients affected by bipolar depression. Methods: With a correlational design, we studied 57 currently depressed inpatients with bipolar disorder: 19 with and 38 without a positive histor…

AdultMalemedicine.medical_specialtyBipolar DisorderDecision MakingPopulationPrefrontal CortexSuicide Attempted03 medical and health sciences0302 clinical medicinemedicineHumansBipolar disorderPsychiatryPrefrontal cortexeducationCerebral CortexTemporal cortexDepressive DisorderDepressive Disorder Majoreducation.field_of_studyDepressionMood DisordersOrgan SizeMiddle Agedmedicine.disease030227 psychiatry3. Good healthDorsolateral prefrontal cortexSuicidePsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureMood disordersCase-Control StudiesLithium CompoundsMajor depressive disorderFemaleOrbitofrontal cortexPsychologyGoals030217 neurology & neurosurgeryClinical psychology
researchProduct

Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders.

2012

Whether responses to antidepressants differ in bipolar and unipolar depression remains unresolved.We analyzed patient characteristics and outcomes of antidepressant treatment of 1036 depressed patients with bipolar-I or bipolar-II disorder, or unipolar major depression, using bivariate and multivariate methods and survival analysis, testing the hypothesis that responses would be superior in unipolar depression.Antidepressants were given to 84.8% (878/1036) of depressed patients: 58.9% of 93 bipolar-I, 80.1% of 117 bipolar-II, and 91.3% of 668 unipolar disorder cases. The 158 not given antidepressants had more manias/year, spent more months in mania and depression, and were far more likely t…

AdultMalemedicine.medical_specialtyBipolar DisorderMonoamine Oxidase InhibitorsAntidepressive Agents Tricyclicbehavioral disciplines and activitiesInternal medicinemental disordersmedicineHumansBipolar disorderPsychiatrySurvival analysisDepression (differential diagnoses)Depressive Disorder MajorManic MoodMiddle Agedmedicine.diseaseAntidepressive AgentsPsychiatry and Mental healthMoodTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptomPsychologyManiaSelective Serotonin Reuptake InhibitorsActa psychiatrica Scandinavica
researchProduct

[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects

1997

[123I]Iodobenzamide (IBZM) is an iodine-labeled dopamine receptor ligand and can be used to visualize brain D2 receptors in humans with single photon emission computerized tomography (SPECT). The ratio of striatal IBZM uptake to uptake in frontal cortex (ST/FC ratio) represents a semiquantitative measure of D2 receptor binding in the striatum. Our study sample included six patients treated with haloperidol (3.0-8.0 mg/day orally; one patient with an average of 0.9 mg/day intramuscularly), five patients with benperidol (9.0-15.0 mg/day orally) and nine patients treated with clozapine (200.0-600.0 mg/day orally). Typical neuroleptics (TNs) and atypical neuroleptics (ANs) were significantly di…

AdultMalemedicine.medical_specialtyBipolar DisorderPyrrolidinesNeuroscience (miscellaneous)Benperidolchemistry.chemical_compoundIodobenzamideBasal Ganglia DiseasesDopamineInternal medicineDopamine receptor D2medicineHaloperidolHumansRadiology Nuclear Medicine and imagingChlorpromazineClozapineClozapineAgedNeurologic ExaminationPsychiatric Status Rating ScalesTomography Emission-Computed Single-PhotonDepressive Disorder MajorSchizophrenia ParanoidDose-Response Relationship DrugReceptors Dopamine D2business.industryBenperidolBrainMiddle AgedCorpus StriatumFrontal LobePsychiatry and Mental healthEndocrinologychemistryDopamine receptorBenzamidesDopamine AntagonistsHaloperidolFemalebusinessAntipsychotic Agentsmedicine.drugPsychiatry Research: Neuroimaging
researchProduct

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depress…

2017

Abstract Background Early Improvement of depressive symptoms within two weeks of antidepressant treatment is a highly sensitive but less specific predictor of later treatment outcome. The aim of this study was to identify clinical features at treatment initiation which are associated with early improvement and non-improvement as well as to identify variables predicting non-remission in patients showing an early improvement. Methods 889 patients with a major depressive episode according to DSM-IV who had participated in an antidepressant treatment trial served as study sample. Clinical predictors (demographic variables, psychopathology, comorbid disorders) were analysed in 698 (79%) early im…

AdultMalemedicine.medical_specialtyComorbidityAvoidant personality disorderPatient ReadmissionSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsRating scaleInternal medicinemedicineHumansMajor depressive episodePsychiatryAtypical depressionDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptombusiness030217 neurology & neurosurgeryPsychopathologyJournal of Affective Disorders
researchProduct

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response

2019

Obesity is one of the most prevalent somatic comorbidities of Major Depressive Disorder (MDD). We aimed to investigate the relationship between body mass index (BMI) and MDD, the symptomatology of the disorder as well as the outcome of antidepressant treatment.Early medication change (EMC) trial participants with BMI measurement (n = 811) were categorized according to WHO-criteria in normal or low weight (BMI  25), overweight (25- 30), and obese (≥30). Depression severity and BMI was assessed in weekly intervals up to 8 weeks. BMI at baseline and course of BMI during the study were investigated in linear regression models as possible moderators of therapy response. Possible moderators such …

AdultMalemedicine.medical_specialtyComorbidityOverweightWeight GainBody Mass IndexDepressive symptomatology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansObesityDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseObesityAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyAntidepressantMajor depressive disorderFemalemedicine.symptombusinessWeight gainBody mass index030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct

Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major.

2014

Background The multislice multiecho T2* cardiovascular magnetic resonance (CMR) technique allows to detect different patterns of myocardial iron overload (MIO). The aim of this cross-sectional study was to verify the association between cardiac complications (heart failure and arrhythmias), biventricular dysfunction and myocardial fibrosis with different patterns of MIO in thalassemia major (TM) patients. Methods We considered 812 TM patients enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network. The T2* value in all the 16 cardiac segments was evaluated. Results We identified 4 groups of patients: 138 with homogeneous MIO (all segments with T2* < 20 ms), 97 with heterogene…

AdultMalemedicine.medical_specialtyHeart DiseasesThalassemiaIronMyocardial ironMagnetic Resonance Imaging CineMyocardial iron overloadYoung AdultRisk FactorsInternal medicineMedicineDistribution (pharmacology)HumansMultisliceChelation therapyCardiac complicationThalassemia majormedicine.diagnostic_testbusiness.industryMyocardiumbeta-ThalassemiaMagnetic resonance imagingmedicine.diseaseCross-Sectional StudiesHeart failureCardiologyMyocardial fibrosisCardiovascular magnetic resonanceFemaleCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

State dependent posterior hippocampal volume increases in patients with major depressive disorder.

2011

Abstract Background The hippocampal formation has been implicated in etiology and therapy response in major depressive disorder (MDD). However, prospective longitudinal studies investigating volumes in hippocampal subregions and their association with clinical findings are still lacking. Methods Global and regional hippocampal volumes and neuropsychological performance were assessed longitudinally in 15 young patients with unipolar early onset MDD who responded to therapy and 13 matched healthy control subjects. Results Although volumes at baseline did not differ between groups, patients with MDD showed significant posterior hippocampal volume increases during the treatment course (mean obs…

AdultMalemedicine.medical_specialtyHippocampusHippocampal formationNeuropsychological TestsHippocampusYoung AdultInternal medicineNeuroplasticitymedicineHumansLongitudinal StudiesProspective StudiesDepressive Disorder MajorNeuronal PlasticityNeuropsychologyOrgan SizeMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAntidepressive AgentsPsychiatry and Mental healthClinical PsychologyCase-Control StudiesEtiologyCardiologyHippocampal volumeAntidepressantMajor depressive disorderFemalePsychologyNeuroscienceJournal of affective disorders
researchProduct

Characterization of patients with mood disorders for their prevalent temperament and level of hopelessness.

2014

Abstract Background Mood disorders (MD) are disabling conditions throughout the world associated with significant psychosocial impairment. Affective temperaments, as well as hopelessness, may play a significant role in the pathophysiology of MD. The present study was designed to characterize patients with MD for their prevalent affective temperament and level of hopelessness. Methods Five hundred fifty-nine (253 men and 306 women) consecutive adult inpatients were assessed using the Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire version (TEMPS-A), the Gotland Scale for Male Depression (GSMD), the Beck Hopelessness Scale (BHS) and the Mini International Neurop…

AdultMalemedicine.medical_specialtyHyperthymic temperamentBipolar Disordermedia_common.quotation_subjectpsychologyHopemedicineHumansBipolar disorderTemperamentPsychiatryAgedMini-international neuropsychiatric interviewmedia_commonDepressive DisorderDepressive Disorder MajorAdult Aged Anxiety Disorders; psychology Bipolar Disorder; psychology Cross-Sectional Studies Cyclothymic Disorder; psychology Depressive Disorder; Major; psychology Female Hope Humans Irritable Mood Male Middle Aged TemperamentMajorMiddle Agedmedicine.diseaseAnxiety DisordersCyclothymic DisorderIrritable MoodPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMood disordersBeck Hopelessness ScaleMajor depressive disorderAnxietyFemaleTemperamentmedicine.symptomPsychologyClinical psychology
researchProduct

The cortisol awakening response at admission to hospital predicts depression severity after discharge in MDD patients.

2019

Major Depressive Disorder (MDD) is associated with hypothalamic-pituitary-adrenal axis (HPA) dysregulation and altered cortisol awakening response (CAR), a non-invasive biomarker for HPA axis reactivity. We theorized that the CAR resembles the accumulated effects of depression over time, and may therefore predict depressive symptom severity once patients return home following inpatient treatment. Two studies are reported. In Study 1 (n = 101; 57% female), the CAR was measured at intake and self-ratings of depression severity was assessed six weeks following discharge. Study 2 (n = 127; 58% female) was a replication and extension of Study 1 where a follow-up assessment of self-rated depressi…

AdultMalemedicine.medical_specialtyHypothalamo-Hypophyseal SystemCortisol awakening responseAdolescentHydrocortisoneNegative associationSeverity of Illness Index03 medical and health sciencesYoung Adult0302 clinical medicinePatient AdmissionInternal medicinemedicineHumansSalivaBiological PsychiatryDepression (differential diagnoses)AgedDepressive Disorder Majorbusiness.industryAfter dischargeMiddle Agedmedicine.diseasePrognosisPatient Discharge030227 psychiatryPsychiatry and Mental healthMoodMajor depressive disorderBiomarker (medicine)FemalePost treatmentbusiness030217 neurology & neurosurgeryBiomarkersFollow-Up StudiesJournal of psychiatric research
researchProduct

Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy

2014

[Formula: see text] multislice multiecho cardiac magnetic resonance (CMR) allows quantification of the segmental distribution of myocardial iron overload (MIO). We evaluated whether a preferential pattern MIO was preserved between two CMR scans in regularly chelated thalassaemia major (TM) patients.We evaluated prospectively 259 TM patients enrolled in the MIO in Thalassaemia (MIOT) network with a CMR follow-up (FU) study at 18 ± 3 months and significant MIO at baseline. The [Formula: see text] in the 16 segments and the global value were calculated. Four main circumferential regions (anterior, septal, inferior and lateral) were defined. We identified two groups: severe (n = 80, global [For…

AdultMalemedicine.medical_specialtyIron OverloadHeart DiseasesCardiac magnetic resonanceMagnetic Resonance Imaging CineMyocardial ironRisk AssessmentIron storeAnterior regionCohort StudiesMyocardial iron overloadInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingMultisliceProspective StudiesChelation therapyThalassaemia majorbusiness.industryPreferential patternbeta-ThalassemiaThalassaemia majorGeneral MedicineMiddle AgedChelation TherapySurgeryTreatment OutcomeCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceFollow-Up StudiesEuropean Heart Journal – Cardiovascular Imaging
researchProduct